{"text_format":"1","workbook":"xlsx","n_sheets":7,"sheets":["Übersicht","Zyklusdiagramm","Tag 1","Tag 2","Tag 3","Tag 4","Tag 5"],"not_rendered":{"charts":0,"images":1,"macros":1,"external_links":0,"defined_names":968,"comments":7,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Übersicht","index":0,"n_rows":118,"n_cols":11,"rows_kept":118,"cut":false,"hidden":false,"merged":[[109,2,109,6],[0,0,7,0],[0,1,0,9],[8,2,8,10],[10,2,10,10],[7,2,7,10],[1,1,1,4],[2,2,2,4],[15,2,15,10],[9,2,9,10],[11,2,11,10],[14,2,14,10],[12,2,12,10],[13,2,13,10]]}
["Entwurf","R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)",null,null,null,null,null,null,null,null,{"$f":"\"Übersicht Z\" & Zyklusnummer","v":"Übersicht Z1"}]
[null,"Doe, John",null,null,null,"geb.","1967-01-01","Alter",{"$f":"IF(PatientGeboren=0,\"\",DATEDIF(PatientGeboren,NOW(),\"y\") & \"J \" & MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12) & \"M\")","v":"54J 8M"},"Geschlecht","m"]
[null,"Diagnose","diffus großzelliges NHL",null,null,"Stadium","IIB","Therapiemodus","Erstlinie","Erstdiagnose","2021-09-06"]
[null,"Größe",170,"Gewicht",75,"KOF",{"$f":"KG^0.425*GroesseCM^0.725/139.315","v":1.8619954939793939},"Infusionsarm","rechts","Pat-ID",5]
[null,"Serum-Kreatinin",0.8,"Datum"," ",{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(KG,GroesseCM,PatientAlter,PatientGeschlecht,PatientSerumKreatinin)","v":102.31680193617507},"Port","rechts","Auftragsnummer",5]
[null,"Zyklus Nr.",1,"von",6,null,14,{"$f":"ROUND((NOW()-PatientGeboren) / 365,0)","v":55}]
[null,"erster Tag","2021-09-06","Intervalltage",14,"Zyklusende",{"$f":"IF(OR(ISBLANK(Therapiebeginn),ISBLANK(IntervallTage)), \"\", Therapiebeginn+IntervallTage-1)","v":"2021-09-19"},"erster Zyklus","2021-09-06","nächster Zyklus",{"$f":"IF(OR(ISBLANK(Therapiebeginn),ISBLANK(IntervallTage),EmpfZyklen=1),\"\",Therapiebeginn+IntervallTage)","v":"2021-09-20"}]
[null,"Hinweise"]
[null,"Risiken","Emetogenität (MASCC/ESMO): moderat (30% - 90%); Neutropenie: sehr hoch (> 41%); febrile Neutropenie: hoch (> 20%); Anämie Hb unter 8g/dl: hoch (16% - 30%); Neuropathie: CTC AE (°3-4:  7%)"]
[null,"Klassifikation","aktueller Standard; Intensität: Standard-Dosis; Modus: Erstlinie; Intention: kurativ"]
[null,"Indikationen","NHL, B-Zell-Typ, diffus großzelliges; NHL, B-Zell-Typ, follikuläres Grad IIIb"]
[null,"Empfehlungen","Onkopedia, ESMO, NCCN"]
[null,"Herkunft","Kooperation: German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), RICOVER-60; ursprünglicher Autor: Pfreundschuh M"]
[null,"Literatur","Pfreundschuh M, Lancet Oncol 2008 Feb;9(2):105-16"]
[null,null,"Brusamolino E, Haematologica 2006 Apr;91(4):496-502"]
[null,null,"Cunningham D, Lancet 2013 May 25;381(9880):1817-26"]
[null,"Dateipfad",{"$f":"optiFilename()","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,"Tag",1,2,3,4,5]
[null,"Datum",{"$f":"Therapiebeginn","v":"2021-09-06"},{"$f":"PDateOV_1+1","v":"2021-09-07"},{"$f":"PDateOV_2+1","v":"2021-09-08"},{"$f":"PDateOV_3+1","v":"2021-09-09"},{"$f":"PDateOV_4+1","v":"2021-09-10"}]
[null,"Flüssigkeitszufuhr: Jonosteril"]
[null,"Jonosteril (i.v.)",{"$f":"PMSID_4241_1_A_D","v":500},{"$f":"PMSID_4241_2_A_D","v":0},{"$f":"PMSID_4241_3_A_D","v":0},{"$f":"PMSID_4241_4_A_D","v":0},{"$f":"PMSID_4241_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",500,500,500,500,500]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)"]
[null,"Paracetamol (p.o.)",{"$f":"PMSID_4242_1_A_D","v":1000},{"$f":"PMSID_4242_2_A_D","v":0},{"$f":"PMSID_4242_3_A_D","v":0},{"$f":"PMSID_4242_4_A_D","v":0},{"$f":"PMSID_4242_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",1000,1000,1000,1000,1000]
[]
[null,"Dimetinden (i.v.)",{"$f":"PMSID_4243_1_A_D","v":4},{"$f":"PMSID_4243_2_A_D","v":0},{"$f":"PMSID_4243_3_A_D","v":0},{"$f":"PMSID_4243_4_A_D","v":0},{"$f":"PMSID_4243_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",4,4,4,4,4]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3"]
[null,"Granisetron (i.v.)",{"$f":"PMSID_4244_1_A_D","v":1},{"$f":"PMSID_4244_2_A_D","v":0},{"$f":"PMSID_4244_3_A_D","v":0},{"$f":"PMSID_4244_4_A_D","v":0},{"$f":"PMSID_4244_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",1,1,1,1,1]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid"]
[null,"Mesna (i.v.)",{"$f":"PMSID_4245_1_A_D","v":279.29932409690906},{"$f":"PMSID_4245_2_A_D","v":0},{"$f":"PMSID_4245_3_A_D","v":0},{"$f":"PMSID_4245_4_A_D","v":0},{"$f":"PMSID_4245_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",150,150,150,150,150]
[]
[null,"Mesna (p.o.)",{"$f":"PMSID_4246_1_A_D","v":558.59864819381812},{"$f":"PMSID_4246_2_A_D","v":0},{"$f":"PMSID_4246_3_A_D","v":0},{"$f":"PMSID_4246_4_A_D","v":0},{"$f":"PMSID_4246_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",300,300,300,300,300]
[]
[null,"Mesna (p.o.)",{"$f":"PMSID_4247_1_A_D","v":558.59864819381812},{"$f":"PMSID_4247_2_A_D","v":0},{"$f":"PMSID_4247_3_A_D","v":0},{"$f":"PMSID_4247_4_A_D","v":0},{"$f":"PMSID_4247_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",300,300,300,300,300]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)"]
[null,"Prednisolon (p.o., 1-0-0-0)",{"$f":"PMSID_4240_1_A_D","v":100},{"$f":"PMSID_4240_2_A_D","v":100},{"$f":"PMSID_4240_3_A_D","v":100},{"$f":"PMSID_4240_4_A_D","v":100},{"$f":"PMSID_4240_5_A_D","v":100}]
[null,"% Dosis",1,1,1,1,1]
[null,"normale Dosierung",100,100,100,100,100]
[]
[null,"Rituximab (i.v.)",{"$f":"PMSID_4236_1_A_D","v":698.24831024227274},{"$f":"PMSID_4236_2_A_D","v":0},{"$f":"PMSID_4236_3_A_D","v":0},{"$f":"PMSID_4236_4_A_D","v":0},{"$f":"PMSID_4236_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",375,375,375,375,375]
[]
[null,"Cyclophosphamid (i.v.)",{"$f":"PMSID_4237_1_A_D","v":1396.4966204845455},{"$f":"PMSID_4237_2_A_D","v":0},{"$f":"PMSID_4237_3_A_D","v":0},{"$f":"PMSID_4237_4_A_D","v":0},{"$f":"PMSID_4237_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",750,750,750,750,750]
[]
[null,"Doxorubicin (i.v.)",{"$f":"PMSID_4238_1_A_D","v":93.099774698969696},{"$f":"PMSID_4238_2_A_D","v":0},{"$f":"PMSID_4238_3_A_D","v":0},{"$f":"PMSID_4238_4_A_D","v":0},{"$f":"PMSID_4238_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",50,50,50,50,50]
[]
[null,"Vincristin (i.v.)",{"$f":"PMSID_4239_1_A_D","v":2},{"$f":"PMSID_4239_2_A_D","v":0},{"$f":"PMSID_4239_3_A_D","v":0},{"$f":"PMSID_4239_4_A_D","v":0},{"$f":"PMSID_4239_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",2,2,2,2,2]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin"]
[null,"Jonosteril (i.v.)",{"$f":"PMSID_4248_1_A_D","v":250},{"$f":"PMSID_4248_2_A_D","v":0},{"$f":"PMSID_4248_3_A_D","v":0},{"$f":"PMSID_4248_4_A_D","v":0},{"$f":"PMSID_4248_5_A_D","v":0}]
[null,"% Dosis",1,0,0,0,0]
[null,"normale Dosierung",250,250,250,250,250]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert"]
[null,"Pegfilgrastim (s.c.)",{"$f":"PMSID_4249_1_A_D","v":0},{"$f":"PMSID_4249_2_A_D","v":6},{"$f":"PMSID_4249_3_A_D","v":0},{"$f":"PMSID_4249_4_A_D","v":0},{"$f":"PMSID_4249_5_A_D","v":0}]
[null,"% Dosis",0,1,0,0,0]
[null,"normale Dosierung",6,6,6,6,6]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien"]
[null,"Cotrimoxazol (p.o., 1-0-0-0)",{"$f":"PMSID_4251_1_A_D","v":960},{"$f":"PMSID_4251_2_A_D","v":0},{"$f":"PMSID_4251_3_A_D","v":960},{"$f":"PMSID_4251_4_A_D","v":0},{"$f":"PMSID_4251_5_A_D","v":960}]
[null,"% Dosis",1,0,1,0,1]
[null,"normale Dosierung",960,960,960,960,960]
[]
[null,"Amphotericin B (p.o., 1-1-1-1)",{"$f":"PMSID_4252_1_A_D","v":100},{"$f":"PMSID_4252_2_A_D","v":100},{"$f":"PMSID_4252_3_A_D","v":100},{"$f":"PMSID_4252_4_A_D","v":100},{"$f":"PMSID_4252_5_A_D","v":100}]
[null,"% Dosis",1,1,1,1,1]
[null,"normale Dosierung",100,100,100,100,100]
[]
[null,"Sonstige Therapie: "]
[null,"[Substanznamen eingeben]",{"$f":"PMSID_1_1_A_D","v":0},{"$f":"PMSID_1_2_A_D","v":0},{"$f":"PMSID_1_3_A_D","v":0},{"$f":"PMSID_1_4_A_D","v":0},{"$f":"PMSID_1_5_A_D","v":0}]
[null,"p.o.",0,0,0,0,0]
[null,"mg",0,0,0,0,0]
[]
[null,"[Substanznamen eingeben]",{"$f":"PMSID_2_1_A_D","v":0},{"$f":"PMSID_2_2_A_D","v":0},{"$f":"PMSID_2_3_A_D","v":0},{"$f":"PMSID_2_4_A_D","v":0},{"$f":"PMSID_2_5_A_D","v":0}]
[null,"p.o.",0,0,0,0,0]
[null,"mg",0,0,0,0,0]
[]
[null,"[Substanznamen eingeben]",{"$f":"PMSID_3_1_A_D","v":0},{"$f":"PMSID_3_2_A_D","v":0},{"$f":"PMSID_3_3_A_D","v":0},{"$f":"PMSID_3_4_A_D","v":0},{"$f":"PMSID_3_5_A_D","v":0}]
[null,"p.o.",0,0,0,0,0]
[null,"mg",0,0,0,0,0]
[]
[null,"[Substanznamen eingeben]",{"$f":"PMSID_4_1_A_D","v":0},{"$f":"PMSID_4_2_A_D","v":0},{"$f":"PMSID_4_3_A_D","v":0},{"$f":"PMSID_4_4_A_D","v":0},{"$f":"PMSID_4_5_A_D","v":0}]
[null,"p.o.",0,0,0,0,0]
[null,"mg",0,0,0,0,0]
[]
[null,"Kontrollen"]
[null,"Tag -1: Echokardiographie, EKG, Rö Thorax"]
[null,"Tag -1: Hepatitis B (HBV) Test: HBsAg und anti-HBc"]
[null,"Tag -1: IgG"]
[null,"Tag 1: GOT, GPT, GGT, Bilirubin, AP, Cholinesterase"]
[null,"Tag 1: Kreatinin, kalkulierte GFR"]
[null,"Tag 1: Urin-Status"]
[null,"Tag 1: Na+, K+, Ca2+, Mg2+"]
[null,"Blutbild: an Tag 1 und in Folge wöchentlich"]

{"sheet":"Zyklusdiagramm","index":1,"n_rows":67,"n_cols":39,"rows_kept":67,"cut":false,"hidden":false,"merged":[[62,2,62,38],[63,2,63,38],[64,2,64,38],[65,2,65,38],[66,2,66,38],[44,19,44,38],[45,19,45,38],[50,2,50,38],[60,2,60,38],[61,2,61,38],[9,2,9,8],[9,9,9,15],[1,35,1,38],[1,21,1,25],[1,26,1,29],[4,21,4,25],[2,26,2,29],[1,30,1,34],[2,30,2,34],[3,30,3,34],[4,30,4,34],[3,35,3,38],[2,35,2,38],[2,21,2,25],[4,26,4,29],[3,21,3,25],[3,26,3,29],[4,9,4,12],[5,2,5,4],[4,13,4,16],[5,9,5,12],[5,13,5,16],[4,2,4,4],[1,13,1,16],[3,5,3,8],[3,13,3,16],[2,13,2,16],[2,2,2,12],[0,0,7,0],[5,35,5,38],[5,17,5,20],[5,5,5,8],[5,30,5,34],[5,26,5,29],[5,21,5,25],[4,17,4,20],[4,5,4,8],[0,1,0,32],[3,9,3,12],[3,2,3,4],[1,17,1,20],[2,17,2,20],[3,17,3,20],[1,1,1,12]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"\"Zyklusdiagramm Z\" & Zyklusnummer","v":"Zyklusdiagramm Z1"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,null,null,null,null,null,null,null,"geb.",null,null,null,{"$f":"PatientGeboren","v":"1967-01-01"},null,null,null,"Alter",null,null,null,null,{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},null,null,null,"Geschlecht",null,null,null,null,{"$f":"PatientGeschlecht","v":"m"}]
[null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"\",Diagnose)","v":"diffus großzelliges NHL"},null,null,null,null,null,null,null,null,null,null,"Stadium",null,null,null,{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},null,null,null,"Therapiemodus",null,null,null,null,{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},null,null,null,"Pat-ID",null,null,null,null,{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,"Größe",{"$f":"GroesseCM","v":170},null,null,"Gewicht",null,null,null,{"$f":"KG","v":75},null,null,null,"KOF",null,null,null,{"$f":"KOF","v":1.8619954939793939},null,null,null,"Infusionsarm",null,null,null,null,{"$f":"PatientInfusionsarm","v":"rechts"},null,null,null,"Auftragsnr.",null,null,null,null,{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,"Serum-Kreatinin",{"$f":"PatientSerumKreatinin","v":0.8},null,null,{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},null,null,null,{"$f":"PatientKreatininClearance","v":102.31680193617507},null,null,null,"Datum",null,null,null,{"$f":"PatientSerumKreatininDatum","v":" "},null,null,null,"Port",null,null,null,null,{"$f":"PatientPort","v":"rechts"}]
[null,"Zyklus Nr",{"$f":"Zyklusnummer","v":1},null,null,"von",null,null,null,{"$f":"EmpfZyklen","v":6},null,null,null,"Intervalltage",null,null,null,{"$f":"IntervallTage","v":14},null,null,null,"erster Tag",null,null,null,null,{"$f":"Therapiebeginn","v":"2021-09-06"},null,null,null,"nächster Zyklus",null,null,null,null,{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[]
[null,null,{"$f":"\"Woche \" & IF(C12<0,C12/7,I12/7)","v":"Woche 1"},null,null,null,null,null,null,{"$f":"\"Woche \" & IF(J12<0,J12/7,P12/7)","v":"Woche 2"}]
[null,null,{"$f":"PDateOV_1","v":"2021-09-06"},{"$f":"PDateOV_2","v":"2021-09-07"},{"$f":"PDateOV_3","v":"2021-09-08"},{"$f":"PDateOV_4","v":"2021-09-09"},{"$f":"PDateOV_5","v":"2021-09-10"},{"$f":"G11+1","v":"2021-09-11"},"2021-09-12","2021-09-13","2021-09-14","2021-09-15","2021-09-16","2021-09-17","2021-09-18","2021-09-19"]
[null,"Flüssigkeitszufuhr",1,{"$f":"IF(C12=-1,1,C12+1)","v":2},{"$f":"IF(D12=-1,1,D12+1)","v":3},4,5,6,7,8,9,10,11,12,13,14]
[null,"Jonosteril (i.v.)"]
[null,"Allergieprophylaxe"]
[null,"Paracetamol (p.o.)"]
[null,"Dimetinden (i.v.)"]
[null,"Antiemese"]
[null,"Granisetron (i.v.)"]
[null,"Supportive Therapie"]
[null,"Mesna (i.v.)"]
[null,"Mesna (p.o.)"]
[null,"Mesna (p.o.)"]
[null,"Medikamentöse Tumortherapie"]
[null,"Prednisolon (p.o., 1-0-0-0)"]
[null,"Rituximab (i.v.)"]
[null,"Cyclophosphamid (i.v.)"]
[null,"Doxorubicin (i.v.)"]
[null,"Vincristin (i.v.)"]
[null,"Flüssigkeitszufuhr"]
[null,"Jonosteril (i.v.)"]
[null,"Hämatopoetische Wachstumsfaktoren"]
[null,"Pegfilgrastim (s.c.)"]
[null,"Infektionsprophylaxe"]
[null,"Cotrimoxazol (p.o., 1-0-0-0)"]
[null,"Amphotericin B (p.o., 1-1-1-1)"]
[null,"Sonstige Therapie"]
[null,"[Substanznamen eingeben]"]
[null,"[Substanznamen eingeben]"]
[null,"[Substanznamen eingeben]"]
[null,"[Substanznamen eingeben]"]
[]
[]
[null,"Dauermedikation","Achtung: In der Dauermedikation sind ggf. Medikamentabgaben enthalten, für die keine Tagesblätter existieren."]
[null,"Infektionsprophylaxe","Infektionsprophylaxe oral,  lymphatische Neoplasien"]
[null,"Tagesdosen beachten","Tag 1,3,5,8,10,12, 1-0-0-0, Cotrimoxazol 960 mg",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Dosismodifikation hier eintragen, falls kein Tagesblatt vorliegt."]
[null,"Tagesdosen beachten","Tag 1-14, 1-1-1-1, Amphotericin B 100 mg",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Dosismodifikation hier eintragen, falls kein Tagesblatt vorliegt."]
[]
[]
[]
[]
[null,"Kontrollen"]
[null,"Tag -1: Echokardiographie, EKG, Rö Thorax"]
[null,"Tag -1: Hepatitis B (HBV) Test: HBsAg und anti-HBc"]
[null,"Tag -1: IgG"]
[null,"Tag 1: GOT, GPT, GGT, Bilirubin, AP, Cholinesterase"]
[null,"Tag 1: Kreatinin, kalkulierte GFR"]
[null,"Tag 1: Urin-Status"]
[null,"Tag 1: Na+, K+, Ca2+, Mg2+"]
[null,"Blutbild: an Tag 1 und in Folge wöchentlich"]
[]
[null,"Dosierungsbemerkungen"]
[null,"Jonosteril","oder vergleichbare isotone kristalloide Elektrolytlösung"]
[null,"Granisetron","oder anderer 5-HT3-Rezeptorantagonist. \n"]
[null,"Prednisolon","Mindestens 60 Minuten vor Rituximab an Tag 1 verabreichen."]
[null,"Rituximab","Init. Infusionsgeschwindigkeit 50mg/h; sie kann alle 30min um 50mg/h auf max. 400mg/h gesteigert werden. \nWeitere Infusionen: init. Infusionsgeschwindigkeit 100mg/h, die alle 30min um 100mg/h bis max. 400mg/h gesteigert werden kann."]
[null,"Cotrimoxazol","kontinuierliche Gabe 3 mal wöchentlich, weiter bis d14 des letzten Zyklus"]
[null,"Amphotericin B","1 Pipette à 1 ml (100mg), weiter kontinuierliche Gabe bis d14 des letzten Zyklus"]

{"sheet":"Tag 1","index":2,"n_rows":58,"n_cols":12,"rows_kept":58,"cut":false,"hidden":false,"merged":[[58,6,58,7],[58,8,58,9],[55,6,55,7],[55,8,55,9],[56,6,56,7],[56,8,56,9],[57,6,57,7],[57,8,57,9],[52,6,52,7],[52,8,52,9],[53,6,53,7],[53,8,53,9],[54,6,54,7],[54,8,54,9],[48,6,48,7],[48,8,48,9],[49,6,49,7],[49,8,49,9],[51,6,51,7],[51,8,51,9],[44,6,44,7],[44,8,44,9],[46,6,46,7],[46,8,46,9],[47,6,47,7],[47,8,47,9],[40,6,40,7],[40,8,40,9],[41,6,41,7],[41,8,41,9],[43,6,43,7],[43,8,43,9],[36,6,36,7],[36,8,36,9],[37,6,37,7],[37,8,37,9],[38,6,38,7],[38,8,38,9],[33,6,33,7],[33,8,33,9],[34,6,34,7],[34,8,34,9],[35,6,35,7],[35,8,35,9],[30,6,30,7],[30,8,30,9],[31,6,31,7],[31,8,31,9],[32,6,32,7],[32,8,32,9],[26,6,26,7],[26,8,26,9],[27,6,27,7],[27,8,27,9],[29,6,29,7],[29,8,29,9],[23,6,23,7],[23,8,23,9],[24,6,24,7],[24,8,24,9],[25,6,25,7],[25,8,25,9],[19,6,19,7],[19,8,19,9],[20,6,20,7],[20,8,20,9],[22,6,22,7],[22,8,22,9],[15,6,15,7],[15,8,15,9],[16,6,16,7],[16,8,16,9],[17,6,17,7],[17,8,17,9],[11,6,11,7],[11,8,11,9],[12,6,12,7],[12,8,12,9],[14,6,14,7],[14,8,14,9],[0,0,7,0],[0,1,0,9],[1,1,1,5],[2,3,2,5],[9,6,9,7],[9,8,9,9]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,{"$f":"\"Z\" & Zyklusnummer & \"/d\" & F9","v":"Z1/d1"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,"geb.:",{"$f":"PatientGeboren","v":"1967-01-01"},"Alter",{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},"Geschlecht",{"$f":"PatientGeschlecht","v":"m"}]
[null,null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"-\",Diagnose)","v":"diffus großzelliges NHL"},null,null,"Stadium",{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},"Therapiemodus",{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},"Erstdiagnose",{"$f":"IF(ErstdiagnoseDatum,ErstdiagnoseDatum,\"\")","v":"2021-09-06"}]
[null,null,"Größe",{"$f":"GroesseCM","v":170},"Gewicht",{"$f":"KG","v":75},"KOF",{"$f":"KG_1^0.425*GroesseCM_1^0.725/139.315","v":1.8619954939793939},"Infusionsarm",{"$f":"PatientInfusionsarm","v":"rechts"},"Pat-ID",{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,null,"Serum-Kreatinin",{"$f":"PatientSerumKreatinin","v":0.8},"Datum",{"$f":"PatientSerumKreatininDatum","v":" "},{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(F4,D4,PatientAlter,PatientGeschlecht,D5)","v":102.31680193617507},"Port",{"$f":"PatientPort","v":"rechts"},"Auftragsnummer",{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,null,"erster Tag",{"$f":"Therapiebeginn","v":"2021-09-06"},"Anzahl Zyklen",{"$f":"EmpfZyklen","v":6},"Intervalltage",{"$f":"IntervallTage","v":14},"erster Zyklus",{"$f":"DatumErsterZyklus","v":"2021-09-06"},"nächster Zyklus",{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,null,"Therapiedatum",{"$f":"PDateOV_1","v":"2021-09-06"},"Zyklustag:",1,"Zyklus: ",{"$f":"Zyklusnummer","v":1},"Uhrzeit:","00:00:00"]
[null,"Appl. Art","Medikament, Substanz","Dosis, Einheit","normale Dosierung","% Anteil Normaldosis","Trägerlsg. Volumen",null,"Ablauf",null,"Dauer","Hdz. Arzt\nUhrzeit"]
[null,"Flüssigkeitszufuhr: Jonosteril",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4241_1_B_D*1*PMSID_4241_1_F_D","v":500},500,1,"-",null,"60 min vor Rituximab (d1)",null,"60 min"]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"p.o.","Paracetamol",{"$f":"PMSID_4242_1_B_D*1*PMSID_4242_1_F_D","v":1000},1000,1,"50 ml",null,"60 min vor Rituximab (d1)",null,"0 min"]
[]
[null,"i.v.","Dimetinden",{"$f":"PMSID_4243_1_B_D*1*PMSID_4243_1_F_D","v":4},4,1,"NaCl 0,9%, 50 ml",null,"30 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Granisetron",{"$f":"PMSID_4244_1_B_D*1*PMSID_4244_1_F_D","v":1},1,1,"NaCl 0,9%, 50 ml",null,"15 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Mesna",{"$f":"PMSID_4245_1_B_D*KOF_1*PMSID_4245_1_F_D","v":279.29932409690906},150,1,"-",null,"1 min vor Cyclophosphamid (d1)",null,"1 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4246_1_B_D*KOF_1*PMSID_4246_1_F_D","v":558.59864819381812},300,1,"-",null,"60 min nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4247_1_B_D*KOF_1*PMSID_4247_1_F_D","v":558.59864819381812},300,1,"-",null,"5 h nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)",null,null,null,null,null,null,null,null,null,"Zugangsart: zentral venös"]
[null,"p.o.","Prednisolon",{"$f":"PMSID_4240_1_B_D*1*PMSID_4240_1_F_D","v":100},100,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"i.v.","Rituximab",{"$f":"PMSID_4236_1_B_D*KOF_1*PMSID_4236_1_F_D","v":698.24831024227274},375,1,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"4 h"]
[]
[null,"i.v.","Cyclophosphamid",{"$f":"PMSID_4237_1_B_D*KOF_1*PMSID_4237_1_F_D","v":1396.4966204845455},750,1,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"60 min"]
[]
[null,"i.v.","Doxorubicin",{"$f":"PMSID_4238_1_B_D*KOF_1*PMSID_4238_1_F_D","v":93.099774698969696},50,1,"Glucose 5%, 250 ml",null,"Reihenfolge",null,"15 min"]
[]
[null,"i.v.","Vincristin",{"$f":"PMSID_4239_1_B_D*1*PMSID_4239_1_F_D","v":2},2,1,"NaCl 0,9%, 50 ml",null,"Reihenfolge",null,"3 min"]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4248_1_B_D*1*PMSID_4248_1_F_D","v":250},250,1,"-",null,"0 min nach Vincristin  (d1)",null,"15 min"]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"s.c.","Pegfilgrastim",{"$f":"PMSID_4249_1_B_D*1*PMSID_4249_1_F_D","v":0},6,0,"-",null,"24 h nach Vincristin  (d1)",null,"0 min"]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"p.o.","Cotrimoxazol",{"$f":"PMSID_4251_1_B_D*1*PMSID_4251_1_F_D","v":960},960,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"p.o.","Amphotericin B",{"$f":"PMSID_4252_1_B_D*1*PMSID_4252_1_F_D","v":100},100,1,"-",null,"1-1-1-1",null,"0 min"]
[]
[null,"Sonstige Therapie: ",null,null,null,null,null,null,null,null,null,"Zugangsart: Keine Angabe"]
[null,"p.o.",null,{"$f":"PMSID_1_1_B_D*PMSID_1_1_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_2_1_B_D*PMSID_2_1_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_3_1_B_D*PMSID_3_1_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_4_1_B_D*PMSID_4_1_F_D","v":0},0,0,"-",null,"",null,"0 min"]

{"sheet":"Tag 2","index":3,"n_rows":58,"n_cols":12,"rows_kept":58,"cut":false,"hidden":false,"merged":[[58,6,58,7],[58,8,58,9],[55,6,55,7],[55,8,55,9],[56,6,56,7],[56,8,56,9],[57,6,57,7],[57,8,57,9],[52,6,52,7],[52,8,52,9],[53,6,53,7],[53,8,53,9],[54,6,54,7],[54,8,54,9],[48,6,48,7],[48,8,48,9],[49,6,49,7],[49,8,49,9],[51,6,51,7],[51,8,51,9],[44,6,44,7],[44,8,44,9],[46,6,46,7],[46,8,46,9],[47,6,47,7],[47,8,47,9],[40,6,40,7],[40,8,40,9],[41,6,41,7],[41,8,41,9],[43,6,43,7],[43,8,43,9],[36,6,36,7],[36,8,36,9],[37,6,37,7],[37,8,37,9],[38,6,38,7],[38,8,38,9],[33,6,33,7],[33,8,33,9],[34,6,34,7],[34,8,34,9],[35,6,35,7],[35,8,35,9],[30,6,30,7],[30,8,30,9],[31,6,31,7],[31,8,31,9],[32,6,32,7],[32,8,32,9],[26,6,26,7],[26,8,26,9],[27,6,27,7],[27,8,27,9],[29,6,29,7],[29,8,29,9],[23,6,23,7],[23,8,23,9],[24,6,24,7],[24,8,24,9],[25,6,25,7],[25,8,25,9],[19,6,19,7],[19,8,19,9],[20,6,20,7],[20,8,20,9],[22,6,22,7],[22,8,22,9],[15,6,15,7],[15,8,15,9],[16,6,16,7],[16,8,16,9],[17,6,17,7],[17,8,17,9],[11,6,11,7],[11,8,11,9],[12,6,12,7],[12,8,12,9],[14,6,14,7],[14,8,14,9],[0,0,7,0],[0,1,0,9],[1,1,1,5],[2,3,2,5],[9,6,9,7],[9,8,9,9]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,{"$f":"\"Z\" & Zyklusnummer & \"/d\" & F9","v":"Z1/d2"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,"geb.:",{"$f":"PatientGeboren","v":"1967-01-01"},"Alter",{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},"Geschlecht",{"$f":"PatientGeschlecht","v":"m"}]
[null,null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"-\",Diagnose)","v":"diffus großzelliges NHL"},null,null,"Stadium",{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},"Therapiemodus",{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},"Erstdiagnose",{"$f":"IF(ErstdiagnoseDatum,ErstdiagnoseDatum,\"\")","v":"2021-09-06"}]
[null,null,"Größe",{"$f":"GroesseCM_1","v":170},"Gewicht",{"$f":"KG_1","v":75},"KOF",{"$f":"KG_2^0.425*GroesseCM_2^0.725/139.315","v":1.8619954939793939},"Infusionsarm",{"$f":"PatientInfusionsarm","v":"rechts"},"Pat-ID",{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,null,"Serum-Kreatinin",{"$f":"SerumKreatinin_1","v":0.8},"Datum",{"$f":"SerumKreatininDatum_1","v":" "},{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(F4,D4,PatientAlter,PatientGeschlecht,D5)","v":102.31680193617507},"Port",{"$f":"PatientPort","v":"rechts"},"Auftragsnummer",{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,null,"erster Tag",{"$f":"Therapiebeginn","v":"2021-09-06"},"Anzahl Zyklen",{"$f":"EmpfZyklen","v":6},"Intervalltage",{"$f":"IntervallTage","v":14},"erster Zyklus",{"$f":"DatumErsterZyklus","v":"2021-09-06"},"nächster Zyklus",{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,null,"Therapiedatum",{"$f":"PDateOV_2","v":"2021-09-07"},"Zyklustag:",2,"Zyklus: ",{"$f":"Zyklusnummer","v":1},"Uhrzeit:","00:00:00"]
[null,"Appl. Art","Medikament, Substanz","Dosis, Einheit","normale Dosierung","% Anteil Normaldosis","Trägerlsg. Volumen",null,"Ablauf",null,"Dauer","Hdz. Arzt\nUhrzeit"]
[null,"Flüssigkeitszufuhr: Jonosteril",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4241_2_B_D*1*PMSID_4241_2_F_D","v":0},500,0,"-",null,"60 min vor Rituximab (d1)",null,"60 min"]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"p.o.","Paracetamol",{"$f":"PMSID_4242_2_B_D*1*PMSID_4242_2_F_D","v":0},1000,0,"50 ml",null,"60 min vor Rituximab (d1)",null,"0 min"]
[]
[null,"i.v.","Dimetinden",{"$f":"PMSID_4243_2_B_D*1*PMSID_4243_2_F_D","v":0},4,0,"NaCl 0,9%, 50 ml",null,"30 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Granisetron",{"$f":"PMSID_4244_2_B_D*1*PMSID_4244_2_F_D","v":0},1,0,"NaCl 0,9%, 50 ml",null,"15 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Mesna",{"$f":"PMSID_4245_2_B_D*KOF_2*PMSID_4245_2_F_D","v":0},150,0,"-",null,"1 min vor Cyclophosphamid (d1)",null,"1 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4246_2_B_D*KOF_2*PMSID_4246_2_F_D","v":0},300,0,"-",null,"60 min nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4247_2_B_D*KOF_2*PMSID_4247_2_F_D","v":0},300,0,"-",null,"5 h nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)",null,null,null,null,null,null,null,null,null,"Zugangsart: zentral venös"]
[null,"p.o.","Prednisolon",{"$f":"PMSID_4240_2_B_D*1*PMSID_4240_2_F_D","v":100},100,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"i.v.","Rituximab",{"$f":"PMSID_4236_2_B_D*KOF_2*PMSID_4236_2_F_D","v":0},375,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"4 h"]
[]
[null,"i.v.","Cyclophosphamid",{"$f":"PMSID_4237_2_B_D*KOF_2*PMSID_4237_2_F_D","v":0},750,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"60 min"]
[]
[null,"i.v.","Doxorubicin",{"$f":"PMSID_4238_2_B_D*KOF_2*PMSID_4238_2_F_D","v":0},50,0,"Glucose 5%, 250 ml",null,"Reihenfolge",null,"15 min"]
[]
[null,"i.v.","Vincristin",{"$f":"PMSID_4239_2_B_D*1*PMSID_4239_2_F_D","v":0},2,0,"NaCl 0,9%, 50 ml",null,"Reihenfolge",null,"3 min"]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4248_2_B_D*1*PMSID_4248_2_F_D","v":0},250,0,"-",null,"0 min nach Vincristin  (d1)",null,"15 min"]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"s.c.","Pegfilgrastim",{"$f":"PMSID_4249_2_B_D*1*PMSID_4249_2_F_D","v":6},6,1,"-",null,"24 h nach Vincristin  (d1)",null,"0 min"]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"p.o.","Cotrimoxazol",{"$f":"PMSID_4251_2_B_D*1*PMSID_4251_2_F_D","v":0},960,0,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"p.o.","Amphotericin B",{"$f":"PMSID_4252_2_B_D*1*PMSID_4252_2_F_D","v":100},100,1,"-",null,"1-1-1-1",null,"0 min"]
[]
[null,"Sonstige Therapie: ",null,null,null,null,null,null,null,null,null,"Zugangsart: Keine Angabe"]
[null,"p.o.",null,{"$f":"PMSID_1_2_B_D*PMSID_1_2_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_2_2_B_D*PMSID_2_2_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_3_2_B_D*PMSID_3_2_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_4_2_B_D*PMSID_4_2_F_D","v":0},0,0,"-",null,"",null,"0 min"]

{"sheet":"Tag 3","index":4,"n_rows":58,"n_cols":12,"rows_kept":58,"cut":false,"hidden":false,"merged":[[58,6,58,7],[58,8,58,9],[55,6,55,7],[55,8,55,9],[56,6,56,7],[56,8,56,9],[57,6,57,7],[57,8,57,9],[52,6,52,7],[52,8,52,9],[53,6,53,7],[53,8,53,9],[54,6,54,7],[54,8,54,9],[48,6,48,7],[48,8,48,9],[49,6,49,7],[49,8,49,9],[51,6,51,7],[51,8,51,9],[44,6,44,7],[44,8,44,9],[46,6,46,7],[46,8,46,9],[47,6,47,7],[47,8,47,9],[40,6,40,7],[40,8,40,9],[41,6,41,7],[41,8,41,9],[43,6,43,7],[43,8,43,9],[36,6,36,7],[36,8,36,9],[37,6,37,7],[37,8,37,9],[38,6,38,7],[38,8,38,9],[33,6,33,7],[33,8,33,9],[34,6,34,7],[34,8,34,9],[35,6,35,7],[35,8,35,9],[30,6,30,7],[30,8,30,9],[31,6,31,7],[31,8,31,9],[32,6,32,7],[32,8,32,9],[26,6,26,7],[26,8,26,9],[27,6,27,7],[27,8,27,9],[29,6,29,7],[29,8,29,9],[23,6,23,7],[23,8,23,9],[24,6,24,7],[24,8,24,9],[25,6,25,7],[25,8,25,9],[19,6,19,7],[19,8,19,9],[20,6,20,7],[20,8,20,9],[22,6,22,7],[22,8,22,9],[15,6,15,7],[15,8,15,9],[16,6,16,7],[16,8,16,9],[17,6,17,7],[17,8,17,9],[11,6,11,7],[11,8,11,9],[12,6,12,7],[12,8,12,9],[14,6,14,7],[14,8,14,9],[0,0,7,0],[0,1,0,9],[1,1,1,5],[2,3,2,5],[9,6,9,7],[9,8,9,9]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,{"$f":"\"Z\" & Zyklusnummer & \"/d\" & F9","v":"Z1/d3"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,"geb.:",{"$f":"PatientGeboren","v":"1967-01-01"},"Alter",{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},"Geschlecht",{"$f":"PatientGeschlecht","v":"m"}]
[null,null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"-\",Diagnose)","v":"diffus großzelliges NHL"},null,null,"Stadium",{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},"Therapiemodus",{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},"Erstdiagnose",{"$f":"IF(ErstdiagnoseDatum,ErstdiagnoseDatum,\"\")","v":"2021-09-06"}]
[null,null,"Größe",{"$f":"GroesseCM_2","v":170},"Gewicht",{"$f":"KG_2","v":75},"KOF",{"$f":"KG_3^0.425*GroesseCM_3^0.725/139.315","v":1.8619954939793939},"Infusionsarm",{"$f":"PatientInfusionsarm","v":"rechts"},"Pat-ID",{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,null,"Serum-Kreatinin",{"$f":"SerumKreatinin_2","v":0.8},"Datum",{"$f":"SerumKreatininDatum_2","v":" "},{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(F4,D4,PatientAlter,PatientGeschlecht,D5)","v":102.31680193617507},"Port",{"$f":"PatientPort","v":"rechts"},"Auftragsnummer",{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,null,"erster Tag",{"$f":"Therapiebeginn","v":"2021-09-06"},"Anzahl Zyklen",{"$f":"EmpfZyklen","v":6},"Intervalltage",{"$f":"IntervallTage","v":14},"erster Zyklus",{"$f":"DatumErsterZyklus","v":"2021-09-06"},"nächster Zyklus",{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,null,"Therapiedatum",{"$f":"PDateOV_3","v":"2021-09-08"},"Zyklustag:",3,"Zyklus: ",{"$f":"Zyklusnummer","v":1},"Uhrzeit:","00:00:00"]
[null,"Appl. Art","Medikament, Substanz","Dosis, Einheit","normale Dosierung","% Anteil Normaldosis","Trägerlsg. Volumen",null,"Ablauf",null,"Dauer","Hdz. Arzt\nUhrzeit"]
[null,"Flüssigkeitszufuhr: Jonosteril",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4241_3_B_D*1*PMSID_4241_3_F_D","v":0},500,0,"-",null,"60 min vor Rituximab (d1)",null,"60 min"]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"p.o.","Paracetamol",{"$f":"PMSID_4242_3_B_D*1*PMSID_4242_3_F_D","v":0},1000,0,"50 ml",null,"60 min vor Rituximab (d1)",null,"0 min"]
[]
[null,"i.v.","Dimetinden",{"$f":"PMSID_4243_3_B_D*1*PMSID_4243_3_F_D","v":0},4,0,"NaCl 0,9%, 50 ml",null,"30 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Granisetron",{"$f":"PMSID_4244_3_B_D*1*PMSID_4244_3_F_D","v":0},1,0,"NaCl 0,9%, 50 ml",null,"15 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Mesna",{"$f":"PMSID_4245_3_B_D*KOF_3*PMSID_4245_3_F_D","v":0},150,0,"-",null,"1 min vor Cyclophosphamid (d1)",null,"1 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4246_3_B_D*KOF_3*PMSID_4246_3_F_D","v":0},300,0,"-",null,"60 min nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4247_3_B_D*KOF_3*PMSID_4247_3_F_D","v":0},300,0,"-",null,"5 h nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)",null,null,null,null,null,null,null,null,null,"Zugangsart: zentral venös"]
[null,"p.o.","Prednisolon",{"$f":"PMSID_4240_3_B_D*1*PMSID_4240_3_F_D","v":100},100,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"i.v.","Rituximab",{"$f":"PMSID_4236_3_B_D*KOF_3*PMSID_4236_3_F_D","v":0},375,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"4 h"]
[]
[null,"i.v.","Cyclophosphamid",{"$f":"PMSID_4237_3_B_D*KOF_3*PMSID_4237_3_F_D","v":0},750,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"60 min"]
[]
[null,"i.v.","Doxorubicin",{"$f":"PMSID_4238_3_B_D*KOF_3*PMSID_4238_3_F_D","v":0},50,0,"Glucose 5%, 250 ml",null,"Reihenfolge",null,"15 min"]
[]
[null,"i.v.","Vincristin",{"$f":"PMSID_4239_3_B_D*1*PMSID_4239_3_F_D","v":0},2,0,"NaCl 0,9%, 50 ml",null,"Reihenfolge",null,"3 min"]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4248_3_B_D*1*PMSID_4248_3_F_D","v":0},250,0,"-",null,"0 min nach Vincristin  (d1)",null,"15 min"]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"s.c.","Pegfilgrastim",{"$f":"PMSID_4249_3_B_D*1*PMSID_4249_3_F_D","v":0},6,0,"-",null,"24 h nach Vincristin  (d1)",null,"0 min"]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"p.o.","Cotrimoxazol",{"$f":"PMSID_4251_3_B_D*1*PMSID_4251_3_F_D","v":960},960,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"p.o.","Amphotericin B",{"$f":"PMSID_4252_3_B_D*1*PMSID_4252_3_F_D","v":100},100,1,"-",null,"1-1-1-1",null,"0 min"]
[]
[null,"Sonstige Therapie: ",null,null,null,null,null,null,null,null,null,"Zugangsart: Keine Angabe"]
[null,"p.o.",null,{"$f":"PMSID_1_3_B_D*PMSID_1_3_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_2_3_B_D*PMSID_2_3_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_3_3_B_D*PMSID_3_3_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_4_3_B_D*PMSID_4_3_F_D","v":0},0,0,"-",null,"",null,"0 min"]

{"sheet":"Tag 4","index":5,"n_rows":58,"n_cols":12,"rows_kept":58,"cut":false,"hidden":false,"merged":[[58,6,58,7],[58,8,58,9],[55,6,55,7],[55,8,55,9],[56,6,56,7],[56,8,56,9],[57,6,57,7],[57,8,57,9],[52,6,52,7],[52,8,52,9],[53,6,53,7],[53,8,53,9],[54,6,54,7],[54,8,54,9],[48,6,48,7],[48,8,48,9],[49,6,49,7],[49,8,49,9],[51,6,51,7],[51,8,51,9],[44,6,44,7],[44,8,44,9],[46,6,46,7],[46,8,46,9],[47,6,47,7],[47,8,47,9],[40,6,40,7],[40,8,40,9],[41,6,41,7],[41,8,41,9],[43,6,43,7],[43,8,43,9],[36,6,36,7],[36,8,36,9],[37,6,37,7],[37,8,37,9],[38,6,38,7],[38,8,38,9],[33,6,33,7],[33,8,33,9],[34,6,34,7],[34,8,34,9],[35,6,35,7],[35,8,35,9],[30,6,30,7],[30,8,30,9],[31,6,31,7],[31,8,31,9],[32,6,32,7],[32,8,32,9],[26,6,26,7],[26,8,26,9],[27,6,27,7],[27,8,27,9],[29,6,29,7],[29,8,29,9],[23,6,23,7],[23,8,23,9],[24,6,24,7],[24,8,24,9],[25,6,25,7],[25,8,25,9],[19,6,19,7],[19,8,19,9],[20,6,20,7],[20,8,20,9],[22,6,22,7],[22,8,22,9],[15,6,15,7],[15,8,15,9],[16,6,16,7],[16,8,16,9],[17,6,17,7],[17,8,17,9],[11,6,11,7],[11,8,11,9],[12,6,12,7],[12,8,12,9],[14,6,14,7],[14,8,14,9],[0,0,7,0],[0,1,0,9],[1,1,1,5],[2,3,2,5],[9,6,9,7],[9,8,9,9]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,{"$f":"\"Z\" & Zyklusnummer & \"/d\" & F9","v":"Z1/d4"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,"geb.:",{"$f":"PatientGeboren","v":"1967-01-01"},"Alter",{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},"Geschlecht",{"$f":"PatientGeschlecht","v":"m"}]
[null,null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"-\",Diagnose)","v":"diffus großzelliges NHL"},null,null,"Stadium",{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},"Therapiemodus",{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},"Erstdiagnose",{"$f":"IF(ErstdiagnoseDatum,ErstdiagnoseDatum,\"\")","v":"2021-09-06"}]
[null,null,"Größe",{"$f":"GroesseCM_3","v":170},"Gewicht",{"$f":"KG_3","v":75},"KOF",{"$f":"KG_4^0.425*GroesseCM_4^0.725/139.315","v":1.8619954939793939},"Infusionsarm",{"$f":"PatientInfusionsarm","v":"rechts"},"Pat-ID",{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,null,"Serum-Kreatinin",{"$f":"SerumKreatinin_3","v":0.8},"Datum",{"$f":"SerumKreatininDatum_3","v":" "},{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(F4,D4,PatientAlter,PatientGeschlecht,D5)","v":102.31680193617507},"Port",{"$f":"PatientPort","v":"rechts"},"Auftragsnummer",{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,null,"erster Tag",{"$f":"Therapiebeginn","v":"2021-09-06"},"Anzahl Zyklen",{"$f":"EmpfZyklen","v":6},"Intervalltage",{"$f":"IntervallTage","v":14},"erster Zyklus",{"$f":"DatumErsterZyklus","v":"2021-09-06"},"nächster Zyklus",{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,null,"Therapiedatum",{"$f":"PDateOV_4","v":"2021-09-09"},"Zyklustag:",4,"Zyklus: ",{"$f":"Zyklusnummer","v":1},"Uhrzeit:","00:00:00"]
[null,"Appl. Art","Medikament, Substanz","Dosis, Einheit","normale Dosierung","% Anteil Normaldosis","Trägerlsg. Volumen",null,"Ablauf",null,"Dauer","Hdz. Arzt\nUhrzeit"]
[null,"Flüssigkeitszufuhr: Jonosteril",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4241_4_B_D*1*PMSID_4241_4_F_D","v":0},500,0,"-",null,"60 min vor Rituximab (d1)",null,"60 min"]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"p.o.","Paracetamol",{"$f":"PMSID_4242_4_B_D*1*PMSID_4242_4_F_D","v":0},1000,0,"50 ml",null,"60 min vor Rituximab (d1)",null,"0 min"]
[]
[null,"i.v.","Dimetinden",{"$f":"PMSID_4243_4_B_D*1*PMSID_4243_4_F_D","v":0},4,0,"NaCl 0,9%, 50 ml",null,"30 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Granisetron",{"$f":"PMSID_4244_4_B_D*1*PMSID_4244_4_F_D","v":0},1,0,"NaCl 0,9%, 50 ml",null,"15 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Mesna",{"$f":"PMSID_4245_4_B_D*KOF_4*PMSID_4245_4_F_D","v":0},150,0,"-",null,"1 min vor Cyclophosphamid (d1)",null,"1 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4246_4_B_D*KOF_4*PMSID_4246_4_F_D","v":0},300,0,"-",null,"60 min nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4247_4_B_D*KOF_4*PMSID_4247_4_F_D","v":0},300,0,"-",null,"5 h nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)",null,null,null,null,null,null,null,null,null,"Zugangsart: zentral venös"]
[null,"p.o.","Prednisolon",{"$f":"PMSID_4240_4_B_D*1*PMSID_4240_4_F_D","v":100},100,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"i.v.","Rituximab",{"$f":"PMSID_4236_4_B_D*KOF_4*PMSID_4236_4_F_D","v":0},375,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"4 h"]
[]
[null,"i.v.","Cyclophosphamid",{"$f":"PMSID_4237_4_B_D*KOF_4*PMSID_4237_4_F_D","v":0},750,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"60 min"]
[]
[null,"i.v.","Doxorubicin",{"$f":"PMSID_4238_4_B_D*KOF_4*PMSID_4238_4_F_D","v":0},50,0,"Glucose 5%, 250 ml",null,"Reihenfolge",null,"15 min"]
[]
[null,"i.v.","Vincristin",{"$f":"PMSID_4239_4_B_D*1*PMSID_4239_4_F_D","v":0},2,0,"NaCl 0,9%, 50 ml",null,"Reihenfolge",null,"3 min"]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4248_4_B_D*1*PMSID_4248_4_F_D","v":0},250,0,"-",null,"0 min nach Vincristin  (d1)",null,"15 min"]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"s.c.","Pegfilgrastim",{"$f":"PMSID_4249_4_B_D*1*PMSID_4249_4_F_D","v":0},6,0,"-",null,"24 h nach Vincristin  (d1)",null,"0 min"]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"p.o.","Cotrimoxazol",{"$f":"PMSID_4251_4_B_D*1*PMSID_4251_4_F_D","v":0},960,0,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"p.o.","Amphotericin B",{"$f":"PMSID_4252_4_B_D*1*PMSID_4252_4_F_D","v":100},100,1,"-",null,"1-1-1-1",null,"0 min"]
[]
[null,"Sonstige Therapie: ",null,null,null,null,null,null,null,null,null,"Zugangsart: Keine Angabe"]
[null,"p.o.",null,{"$f":"PMSID_1_4_B_D*PMSID_1_4_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_2_4_B_D*PMSID_2_4_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_3_4_B_D*PMSID_3_4_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_4_4_B_D*PMSID_4_4_F_D","v":0},0,0,"-",null,"",null,"0 min"]

{"sheet":"Tag 5","index":6,"n_rows":58,"n_cols":12,"rows_kept":58,"cut":false,"hidden":false,"merged":[[58,6,58,7],[58,8,58,9],[55,6,55,7],[55,8,55,9],[56,6,56,7],[56,8,56,9],[57,6,57,7],[57,8,57,9],[52,6,52,7],[52,8,52,9],[53,6,53,7],[53,8,53,9],[54,6,54,7],[54,8,54,9],[48,6,48,7],[48,8,48,9],[49,6,49,7],[49,8,49,9],[51,6,51,7],[51,8,51,9],[44,6,44,7],[44,8,44,9],[46,6,46,7],[46,8,46,9],[47,6,47,7],[47,8,47,9],[40,6,40,7],[40,8,40,9],[41,6,41,7],[41,8,41,9],[43,6,43,7],[43,8,43,9],[36,6,36,7],[36,8,36,9],[37,6,37,7],[37,8,37,9],[38,6,38,7],[38,8,38,9],[33,6,33,7],[33,8,33,9],[34,6,34,7],[34,8,34,9],[35,6,35,7],[35,8,35,9],[30,6,30,7],[30,8,30,9],[31,6,31,7],[31,8,31,9],[32,6,32,7],[32,8,32,9],[26,6,26,7],[26,8,26,9],[27,6,27,7],[27,8,27,9],[29,6,29,7],[29,8,29,9],[23,6,23,7],[23,8,23,9],[24,6,24,7],[24,8,24,9],[25,6,25,7],[25,8,25,9],[19,6,19,7],[19,8,19,9],[20,6,20,7],[20,8,20,9],[22,6,22,7],[22,8,22,9],[15,6,15,7],[15,8,15,9],[16,6,16,7],[16,8,16,9],[17,6,17,7],[17,8,17,9],[11,6,11,7],[11,8,11,9],[12,6,12,7],[12,8,12,9],[14,6,14,7],[14,8,14,9],[0,0,7,0],[0,1,0,9],[1,1,1,5],[2,3,2,5],[9,6,9,7],[9,8,9,9]]}
["Entwurf",{"$f":"Protokollname","v":"R-CHOP 14 - Rituximab 375 / Cyclophosphamid 750 / Doxorubicin 50 / Vincristin 2 / Prednisolon 100, diffus großzelliges B-Non-Hodgkin-Lymphom, Zyklus 1-6 (PID=112 V1.1)"},null,null,null,null,null,null,null,null,null,{"$f":"\"Z\" & Zyklusnummer & \"/d\" & F9","v":"Z1/d5"}]
[null,{"$f":"IF(PatientName=\"\",\"\",PatientName)","v":"Doe, John"},null,null,null,null,"geb.:",{"$f":"PatientGeboren","v":"1967-01-01"},"Alter",{"$f":"DATEDIF(PatientGeboren,NOW(),\"y\")&\"J \"&MOD(DATEDIF(PatientGeboren,NOW(),\"m\"),12)&\"M\"","v":"54J 8M"},"Geschlecht",{"$f":"PatientGeschlecht","v":"m"}]
[null,null,"Diagnose",{"$f":"IF(Diagnose=\"\",\"-\",Diagnose)","v":"diffus großzelliges NHL"},null,null,"Stadium",{"$f":"IF(Stadium=\"\",\"\",Stadium)","v":"IIB"},"Therapiemodus",{"$f":"IF(Therapiemodus<>\"\",Therapiemodus,\"\")","v":"Erstlinie"},"Erstdiagnose",{"$f":"IF(ErstdiagnoseDatum,ErstdiagnoseDatum,\"\")","v":"2021-09-06"}]
[null,null,"Größe",{"$f":"GroesseCM_4","v":170},"Gewicht",{"$f":"KG_4","v":75},"KOF",{"$f":"KG_5^0.425*GroesseCM_5^0.725/139.315","v":1.8619954939793939},"Infusionsarm",{"$f":"PatientInfusionsarm","v":"rechts"},"Pat-ID",{"$f":"IF(PatientID=\"\",\"\",PatientID)","v":5}]
[null,null,"Serum-Kreatinin",{"$f":"SerumKreatinin_4","v":0.8},"Datum",{"$f":"SerumKreatininDatum_4","v":" "},{"$f":"\"GFR \" & shortGFR(sGFR)","v":"GFR NM"},{"$f":"fGFR(F4,D4,PatientAlter,PatientGeschlecht,D5)","v":102.31680193617507},"Port",{"$f":"PatientPort","v":"rechts"},"Auftragsnummer",{"$f":"IF(Auftragsnummer=\"\",\"\",Auftragsnummer)","v":5}]
[null,null,"erster Tag",{"$f":"Therapiebeginn","v":"2021-09-06"},"Anzahl Zyklen",{"$f":"EmpfZyklen","v":6},"Intervalltage",{"$f":"IntervallTage","v":14},"erster Zyklus",{"$f":"DatumErsterZyklus","v":"2021-09-06"},"nächster Zyklus",{"$f":"nächsterZyklus","v":"2021-09-20"}]
[null,null,"Dateipfad",{"$f":"Dateipfad","v":"C:\\Users\\wicken\\Desktop\\opti-demo-excel\\Demo_R-CHOP 14 (RITU375_CYCL750_DOXO50_VNCR2_PRED100), DLBCL, Z1-6_PID112_V1_1.xlsm"}]
[]
[null,null,"Therapiedatum",{"$f":"PDateOV_5","v":"2021-09-10"},"Zyklustag:",5,"Zyklus: ",{"$f":"Zyklusnummer","v":1},"Uhrzeit:","00:00:00"]
[null,"Appl. Art","Medikament, Substanz","Dosis, Einheit","normale Dosierung","% Anteil Normaldosis","Trägerlsg. Volumen",null,"Ablauf",null,"Dauer","Hdz. Arzt\nUhrzeit"]
[null,"Flüssigkeitszufuhr: Jonosteril",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4241_5_B_D*1*PMSID_4241_5_F_D","v":0},500,0,"-",null,"60 min vor Rituximab (d1)",null,"60 min"]
[]
[null,"Allergieprophylaxe: Rituximab Allergieprophylaxe (Paracetamol, Dimetinden)",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"p.o.","Paracetamol",{"$f":"PMSID_4242_5_B_D*1*PMSID_4242_5_F_D","v":0},1000,0,"50 ml",null,"60 min vor Rituximab (d1)",null,"0 min"]
[]
[null,"i.v.","Dimetinden",{"$f":"PMSID_4243_5_B_D*1*PMSID_4243_5_F_D","v":0},4,0,"NaCl 0,9%, 50 ml",null,"30 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Antiemese: Emetogenität moderat, GRAN i.v., ohne DEXA d1-3",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Granisetron",{"$f":"PMSID_4244_5_B_D*1*PMSID_4244_5_F_D","v":0},1,0,"NaCl 0,9%, 50 ml",null,"15 min vor Rituximab (d1)",null,"5 min"]
[]
[null,"Supportive Therapie: Mesna i.v.,  Stunde 0 (vor), p.o. 2h, 6 h nach Beginn Cyclophosphamid",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Mesna",{"$f":"PMSID_4245_5_B_D*KOF_5*PMSID_4245_5_F_D","v":0},150,0,"-",null,"1 min vor Cyclophosphamid (d1)",null,"1 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4246_5_B_D*KOF_5*PMSID_4246_5_F_D","v":0},300,0,"-",null,"60 min nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"p.o.","Mesna",{"$f":"PMSID_4247_5_B_D*KOF_5*PMSID_4247_5_F_D","v":0},300,0,"-",null,"5 h nach Cyclophosphamid (d1)",null,"0 min"]
[]
[null,"Medikamentöse Tumortherapie: R-CHOP  (RITU + CHOP d1)",null,null,null,null,null,null,null,null,null,"Zugangsart: zentral venös"]
[null,"p.o.","Prednisolon",{"$f":"PMSID_4240_5_B_D*1*PMSID_4240_5_F_D","v":100},100,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"i.v.","Rituximab",{"$f":"PMSID_4236_5_B_D*KOF_5*PMSID_4236_5_F_D","v":0},375,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"4 h"]
[]
[null,"i.v.","Cyclophosphamid",{"$f":"PMSID_4237_5_B_D*KOF_5*PMSID_4237_5_F_D","v":0},750,0,"NaCl 0,9%, 500 ml",null,"Reihenfolge",null,"60 min"]
[]
[null,"i.v.","Doxorubicin",{"$f":"PMSID_4238_5_B_D*KOF_5*PMSID_4238_5_F_D","v":0},50,0,"Glucose 5%, 250 ml",null,"Reihenfolge",null,"15 min"]
[]
[null,"i.v.","Vincristin",{"$f":"PMSID_4239_5_B_D*1*PMSID_4239_5_F_D","v":0},2,0,"NaCl 0,9%, 50 ml",null,"Reihenfolge",null,"3 min"]
[]
[null,"Flüssigkeitszufuhr: Hydrierung nach Vincristin",null,null,null,null,null,null,null,null,null,"Zugangsart: peripher venös"]
[null,"i.v.","Jonosteril",{"$f":"PMSID_4248_5_B_D*1*PMSID_4248_5_F_D","v":0},250,0,"-",null,"0 min nach Vincristin  (d1)",null,"15 min"]
[]
[null,"Hämatopoetische Wachstumsfaktoren: FN-Risiko über 20%, G-CSF langwirksam, pegyliert",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"s.c.","Pegfilgrastim",{"$f":"PMSID_4249_5_B_D*1*PMSID_4249_5_F_D","v":0},6,0,"-",null,"24 h nach Vincristin  (d1)",null,"0 min"]
[]
[null,"Infektionsprophylaxe: Infektionsprophylaxe oral,  lymphatische Neoplasien",null,null,null,null,null,null,null,null,null,"Zugangsart: - entfällt -"]
[null,"p.o.","Cotrimoxazol",{"$f":"PMSID_4251_5_B_D*1*PMSID_4251_5_F_D","v":960},960,1,"-",null,"1-0-0-0",null,"0 min"]
[]
[null,"p.o.","Amphotericin B",{"$f":"PMSID_4252_5_B_D*1*PMSID_4252_5_F_D","v":100},100,1,"-",null,"1-1-1-1",null,"0 min"]
[]
[null,"Sonstige Therapie: ",null,null,null,null,null,null,null,null,null,"Zugangsart: Keine Angabe"]
[null,"p.o.",null,{"$f":"PMSID_1_5_B_D*PMSID_1_5_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_2_5_B_D*PMSID_2_5_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_3_5_B_D*PMSID_3_5_F_D","v":0},0,0,"-",null,"",null,"0 min"]
[]
[null,"p.o.",null,{"$f":"PMSID_4_5_B_D*PMSID_4_5_F_D","v":0},0,0,"-",null,"",null,"0 min"]